Or

Open access

Bioethics

Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study – The BMJ (free)

“Industry payments to journal editors are common and often large, particularly for certain subspecialties. Journals should consider the potential impact of such payments on public trust in published research”.

 


Outcomes In Two Massachusetts Hospital Systems Give Reason For Optimism About Communication-And-Resolution Programs – Health Affairs (link to abstract – $ for full-text)

Commentaries: After medical error, apology goes a long way – Stanford University Medical Center, via ScienceDaily (free) AND Conflict Resolution Program: ‘Cause for Optimism’ – MedPage Today (free registration required)

 


Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities – The Canadian Journal of Psychiatry (link to abstract – $ for full-text)

Commentaries: Antipsychotics common for adults with intellectual and developmental disabilities – Centre for Addiction and Mental Health (free) AND Antipsychotics Overused in Intellectually Disabled Adults – Medscape (free registration required)

“Antipsychotics are used inappropriately particularly in vulnerable groups: Poor children; Intellectually challenged; Autistic; Nursing homes. (RT @AllenFrancesMD see Tweet)

 


FDA News Release: FDA approval brings first gene therapy to the United States (free)

Commentaries: A $475,000 cancer drug: Wall Street sees ‘bargain’; patients see ‘completely broken’ system – HealthNewsReview (free) FDA Approves First CAR-T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia – National Institutes of Health (free) AND FDA Approves First Gene-Altering Leukemia Treatment, Costing $475.000 – New York Times (10 articles per month are free) AND The FDA Approves a Landmark Cancer Drug – The Atlantic (free)

“…is a cancer therapy that represents several things at once: a game-changing way to treat cancer through genetic engineering, a novel paradigm for the biotech business, and the latest turn in the debate over just how astronomically expensive a life-saving therapy can be”. (from The Atlantic)

 


China’s embrace of embryo selection raises thorny questions – Nature News (free)

“Fertility centres are making a massive push to increase preimplantation genetic diagnosis in a bid to eradicate certain diseases”.

 


The global crackdown on parents who refuse vaccines for their kids has begun – VOX (free)

See more on mandatory vaccination in our May 29th (see #6) and July 12th (see #5) issues.

“Countries like Italy and Australia are tired of measles outbreaks — so they’re moving to fine anti-vaccine parents”.

 


Iatrogenesis in Pediatrics – AMA Journal of Ethics (free) (RT @JournalofEthics)

New issue with series of articles exploring strategies clinicians need to know to respond to adverse outcomes.

 


First compute no harm – Enrico Coiera, via The BMJ Opinion (free)

“We will need new principles and regulations to govern medical artificial intelligence”

 


Why cancer is not a war, fight, or battle – CNN (free)

Related: He’s a Fighter – The Atlantic (free)

“Cancer is a process, it’s not a war. No winners or losers. Stop military metaphors”. (RT @lucadf see Tweet)

 


‘We are all mutants now’: the trouble with genetic testing – The Guardian (free) (RT @EricTopol see Tweet)

Related: The uncertain future of genetic testing – Mosaic (free)

“With so many unknowns in our DNA, using genetics in medical testing doesn’t always bring the answers – sometimes it brings only doubt”.

 


Viewpoint: The Evolving Story of Overlapping Surgery – JAMA (free) (RT @pash22 see Tweet)

Commentary: 3 steps to restore patient trust in overlapping surgeries – FierceHealthcare (free)

This interesting viewpoint discusses the practice of scheduling overlapping surgeries, in which a qualified practitioner finishes noncritical parts of the first operation while the primary surgeon moves to the next surgery.

 


Quality of Life in Dementia – The AMA Journal of Ethics (free)

“What can clinicians do to normalize the experience of dementia? Our new issue explores the ethics of dementia care” (RT @JournalofEthics see Tweet)

 


Teaching Clinical Ethics at the Bedside: William Osler and the Essential Role of the Hospitalist – AMA Journal of Ethics (free)

“Hospitalists are uniquely positioned to teach ethics and communication in real time on the wards” (RT @JournalofEthics see Tweet)

 


How Should Resident Physicians Respond to Patients’ Discomfort and Students’ Moral Distress When Learning Procedures in Academic Medical Settings? – AMA Journal of Ethics (free)

“Medical institutions should support a culture of “speaking up” to promote the safety of patients AND learners” (RT @JournalofEthics see Tweet)

 


WHO guidelines on ethical issues in public health surveillance – World Health Organization (free)

Commentary: Ethics of public health surveillance: new guidelines – The Lancet Public Health (free)

Public health surveillance: privacy, autonomy, equity, common good need to be balanced. New ethics guidelines” (RT @trished see Tweet)

 


Insurers Battle Families Over Costly Drug for Fatal Disease – The New York Times (10 articles per month are free)

“A new drug can cost over a million dollars, even though it’s unclear if it works. Now, insurers are refusing to pay” (RT @NYTHealth see Tweet)

 


A Piece of My Mind: Speak Up – JAMA (free)

“Verbal and physical attacks against health care workers are common, are underreported, and have lasting consequences in the form of persistent fear”.

 


The pressure of Big Pharma – The Globe and Mail (a few articles per month are free) (RT @CADTH_ACMTS see Tweet)

“Financial conflicts of interest are commonplace in clinical practice guidelines”

 


Who Should Assess the Needs of and Care for a Dementia Patient’s Caregiver? – AMA Journal of Ethics (free)

“Physicians have an obligation to check in on dementia patients’ caregivers, and provide support if necessary” (RT @JournalofEthics see Tweet)

 


The ‘living dead’: prisoners executed for their organs then sold to foreigners for transplants – News.com.au (free)

“I have to fly tonight because they are shooting my donor tomorrow.”

“Here’s an ethics study. Would you accept organ from executed prisoner if it were a matter of your life or death?” (RT @barttels2 see Tweet)

 


Viewpoint: Direct-to-Consumer Medical Testing in the Era of Value-Based Care – JAMA (free)

See also a recent discussion on direct-to-consumer genetic testing in our April 10th issue, see #5

Others disagree: “Dissing every consumer medical test as “low value”. Sorry, that’s not true. It’s called paternalism” (RT @EricTopol see Tweet)

 


Editor’s Choice: Give patients access to their medical records – The BMJ, by Fiona Godlee, editor in chief (free)

Patients are being empowered in decisions regarding their health care, and this is probably a tendency for the future.

 


Correspondence: Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients – The New England Journal of Medicine (free)

Transplantation of HCV-infected-kidneys into uninfected recipients seems feasible in this era of direct-acting antiviral agents, maybe shortening waiting times for those willing to take the risk.

 


The Patients Were Saved. That’s Why the Families Are Suing – The New York Times (free)

“Historically, the practice has been “if in doubt, err on the side of aggressive, life-sustaining treatment,””. That might be changing.

 


Page 1 of 11
Stay Updated in Your Specialty!
(No spam, just news)